These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24767223)

  • 41. The Effect of Ophthalmic Surgery for Graves' Orbitopathy on Quality of Life: A Systematic Review and Meta-Analysis.
    Woo T; Li C; Ganesananthan S; Rajendram R; Uddin J; Lee RWJ; Dayan C; Taylor P
    Thyroid; 2022 Feb; 32(2):177-187. PubMed ID: 34877883
    [No Abstract]   [Full Text] [Related]  

  • 42. Evaluation of the Graves' Orbitopathy-Specific Quality of Life Questionnaire in the Mainland Chinese Population.
    Zeng P; Fan SX; Li ZJ; Peng YY; Hu YX; Xu MT; Wang M
    J Ophthalmol; 2019; 2019():7602419. PubMed ID: 31011452
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management of thyroid eye disease in the United Kingdom: A multi-centre thyroid eye disease audit.
    Mellington FE; Dayan CM; Dickinson AJ; Hickey JL; MacEwen CJ; McLaren J; Perros P; Rose GE; Uddin J; Vaidya B; Foley P; Lazarus JH; Mitchell A; Ezra DG;
    Orbit; 2017 Jun; 36(3):159-169. PubMed ID: 28296512
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Measuring Health-Related Quality of Life in Thyroid Eye Disease.
    Sharma A; Stan MN; Rootman DB
    J Clin Endocrinol Metab; 2022 Aug; 107(Suppl_1):S27-S35. PubMed ID: 36346683
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of the National Eye Institute visual function questionnaire in Graves' ophthalmopathy.
    Bradley EA; Sloan JA; Novotny PJ; Garrity JA; Woog JJ; West SK
    Ophthalmology; 2006 Aug; 113(8):1450-4. PubMed ID: 16769116
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantification of Global Ocular Motility Impairment in Graves' Orbitopathy by Measuring Eye Muscle Ductions.
    Campi I; Currò N; Vannucchi G; Covelli D; Simonetta S; Fugazzola L; Dazzi D; Pignataro L; Guastella C; Lazzaroni E; Pirola G; Salvi M
    Thyroid; 2021 Feb; 31(2):280-287. PubMed ID: 32940167
    [No Abstract]   [Full Text] [Related]  

  • 47. The "Quiet TED"-A Special Subgroup of Thyroid Eye Disease.
    Iñiguez-Ariza NM; Sharma A; Garrity JA; Stan MN
    Ophthalmic Plast Reconstr Surg; 2021 Nov-Dec 01; 37(6):551-555. PubMed ID: 33782324
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correlation of clinical and radiological scores for evaluation of activity in patients having thyroid-associated orbitopathy: A prospective observational study.
    Singh M; Rana N; Ahuja C; Gupta P; Zadeng Z
    Indian J Ophthalmol; 2024 Jun; 72(6):844-848. PubMed ID: 38804801
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quality of life improves after strabismus surgery in patients with Graves' orbitopathy.
    Jellema HM; Merckel-Timmer E; Kloos R; Saeed P; Mourits MP
    Eur J Endocrinol; 2014 May; 170(5):785-9. PubMed ID: 24493116
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The relationship between quality of life, cognition, and thyroid status in Graves' disease.
    Riguetto CM; Neto AM; Tambascia MA; Zantut-Wittmann DE
    Endocrine; 2019 Jan; 63(1):87-93. PubMed ID: 30173328
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Longitudinal association of thyroid-stimulating immunoglobulin levels with clinical characteristics in thyroid eye disease.
    Ko J; Kook KH; Yoon JS; Woo KI; Yang JW;
    BMJ Open; 2022 Jun; 12(6):e050337. PubMed ID: 35728893
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hyperthyroid vs hypothyroid eye disease: the same severity and activity.
    Kashkouli MB; Pakdel F; Kiavash V; Heidari I; Heirati A; Jam S
    Eye (Lond); 2011 Nov; 25(11):1442-6. PubMed ID: 21818129
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quality of life in thyroid eye disease: impact of quality of care.
    Estcourt S; Quinn AG; Vaidya B
    Eur J Endocrinol; 2011 May; 164(5):649-55. PubMed ID: 21367964
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quality of life in Graves' ophthalmopathy.
    Wiersinga WM
    Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):359-70. PubMed ID: 22632371
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Corneal biomechanical properties in thyroid eye disease.
    Karabulut GO; Kaynak P; Altan C; Ozturker C; Aksoy EF; Demirok A; Yılmaz OF
    Kaohsiung J Med Sci; 2014 Jun; 30(6):299-304. PubMed ID: 24835350
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessing quality of life in Australian patients with Graves' ophthalmopathy.
    Park JJ; Sullivan TJ; Mortimer RH; Wagenaar M; Perry-Keene DA
    Br J Ophthalmol; 2004 Jan; 88(1):75-8. PubMed ID: 14693779
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thyroid Eye Disease: Pilot Study Comparison Between Patients in United States-Based and India-Based Practices.
    Ramesh S; Naik M; Watson A; Zhang Q; Peskin E; Sharpe J; Alessi K; Hyman L
    Am J Ophthalmol; 2024 Aug; 264():25-35. PubMed ID: 38484865
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of orbital soft tissue biomechanical parameters in patients with thyroid eye disease using the non-contact Corvis ST.
    Moeen Rad A; Zarei-Ghanavati S; Sabermoghaddam A; Ghavami Shahri SH; Bakhtiari E; Kiarudi MY
    Int Ophthalmol; 2023 Oct; 43(10):3615-3621. PubMed ID: 37393605
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ocular Hypertension, Glaucoma or Compressive Neuropathy in Patient with Active TED.
    Stoyanova NS; Konareva-Kostianeva MI; Mitkova-Hristova VT
    Folia Med (Plovdiv); 2020 Jun; 62(2):418-423. PubMed ID: 32666771
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterizing Intraorbital Optic Nerve Changes on Diffusion Tensor Imaging in Thyroid Eye Disease Before Dysthyroid Optic Neuropathy.
    Lee H; Lee YH; Suh SI; Jeong EK; Baek S; Seo HS
    J Comput Assist Tomogr; 2018; 42(2):293-298. PubMed ID: 28937496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.